Plain-English translation of NCT07858019 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Australia
New Zealand
Phase
Safety & dosing
Sponsor
Corsera Health
Enrollment target
~108 participants
Started
October 2026
Primary completion
August 2027
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in October 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Corsera Clinical Trial Information Line
Corsera Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.